Verrica Pharmaceuticals Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 17
Employees
  • Stock Symbol
  • VRCA
Stock Symbol
  • Share Price
  • $11.76
  • (As of Wednesday Closing)

Verrica Pharmaceuticals General Information

Description

Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • Durham, NC
  • United States
+1 (610) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Verrica Pharmaceuticals Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$11.76 $11.12 $6.02 - $17.60 $304M 25.9M 69.2K -$1.50

Verrica Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 155,026 338,707 112,450
Revenue 0 0 0 0
EBITDA (35,889) (29,827) (21,859) (4,457)
Net Income (37,354) (28,207) (20,648) (4,459)
Total Assets 79,936 68,424 91,906 9,083
Total Debt 36,976 188 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Verrica Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request a free trial

Verrica Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request a free trial

Verrica Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of no
Drug Discovery
Durham, NC
17 As of 2019
00000
000000 - 000 00000

0000000

ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco labori
000000000000000
Wayne, PA
00 As of 0000
00000
00000000000 00000

00000000

ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
000000000000000
Houston, TX
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Verrica Pharmaceuticals Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Aclaris Therapeutics Formerly VC-backed Wayne, PA 00 00000 00000000000 00000
000000000 Formerly PE-Backed Houston, TX 00 000.00 000000000 000.00
00000000 000000000 Private Debt Financed San Diego, CA 00 000000000 -
0000 0000000000000 Formerly PE-Backed West Chester, PA 000000&0
000000 Formerly PE-Backed Newport Beach, CA 000 00000 00000000 00000
You’re viewing 5 of 8 competitors. Get the full list »

Verrica Pharmaceuticals Executive Team (6)

Name Title Board Seat Contact Info
Ted White Chief Executive Officer & Board Member
Matthew Davidson Ph.D Founder, Chief Scientific Officer & Board Member
Patrick Burnett Ph.D Chief Medical Officer
You’re viewing 3 of 6 executive team members. Get the full list »

Verrica Pharmaceuticals Board Members (8)

Name Representing Role Since
Lawrence Eichenfield MD Self Board Member 000 0000
Matthew Davidson Ph.D Verrica Pharmaceuticals Founder, Chief Scientific Officer & Board Member 000 0000
Paul Manning PBM Capital Group Chairman & Board Member 000 0000
Sean Stalfort Verrica Pharmaceuticals Board Member 000 0000
Ted White Verrica Pharmaceuticals Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Verrica Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Verrica Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Verrica Pharmaceuticals‘s full profile, request access.

Request a free trial